Ocean Biomedical Inc. - OCEA STOCK NEWS

IMPACT

SENTIMENT

12/05/2023 08:15 AM

OCEA : Nasdaq

Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody

IMPACT

SENTIMENT

11/29/2023 05:41 PM

OCEA : Nasdaq

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

IMPACT

SENTIMENT

11/14/2023 08:01 AM

OCEA : Nasdaq

Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics

IMPACT

SENTIMENT

10/26/2023 05:30 AM

OCEA : Nasdaq

Virion Therapeutics and Joint Venture Partner, Ocean Biomedical (NASDAQ: OCEA), Announce First Patients Dosed with Novel Immunotherapy Evaluating a Functional Cure for Chronic Hepatitis B Virus Infection

IMPACT

SENTIMENT

10/26/2023 05:30 AM

OCEA : Nasdaq

Ocean Biomedical (NASDAQ: OCEA) Announces First Patients Dosed by Joint Venture Partner Virion Therapeutics in Phase 1b Study of Novel Immunotherapy for Chronic Hepatitis B Virus Infection

IMPACT

SENTIMENT

10/24/2023 06:30 AM

OCEA : Nasdaq

Ocean Biomedical (NASDAQ: OCEA) Announces $1 Million Falk Award for Malaria Drug Candidate Addressing Evolving Resistance to Artemisinin-Based Therapeutics to Chief Scientist Dr. Jonathan Kurtis

IMPACT

SENTIMENT

10/17/2023 08:01 AM

OCEA : Nasdaq

Ocean Biomedical (NASDAQ: OCEA) Announces Enrollment of Patients for Phase 1b Study for Chronic Hepatitis B Treatment in 50-50 Joint Venture with Virion Therapeutics

IMPACT

SENTIMENT

10/12/2023 08:01 AM

OCEA : Nasdaq

Ocean Biomedical and Virion Therapeutics Form Joint Venture Supporting Multi-National, First-In-Humans Clinical Chronic Hepatitis B Study: Now Enrolling, With Goal of a Functional Cure for a Disease Affecting 300+ Million Patients Worldwide

IMPACT

SENTIMENT

10/04/2023 04:56 PM

OCEA : Nasdaq

Updated: Ocean Biomedical Announces Non-Dilutive Amendment to Existing Agreement with Polar Multi-Strategy Master Fund

IMPACT

SENTIMENT

10/04/2023 08:01 AM

OCEA : Nasdaq

Ocean Biomedical Announces Loan Commitment from Largest Stockholder; Up to $10 Million

Ocean Biomedical Inc.

Nasdaq:OCEA

OCEA Rankings

#6512 Ranked by Market Cap

N/A Ranked by Dividends

OCEA Stock Data

Industry Research and Development in Biotechnology

Sector Professional, Scientific, and Technical Services